Beijing
603392.SSBeijing Wantai Biological Pharmacy Enterprise Co., Ltd. Price (603392.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
1,260,282,549
(0.9349)%Revenue and Profitability
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 499,060,636 | 596,233,752 | 680,713,659 | 844,082,335 | 949,524,531 | 982,686,707 | 1,183,754,229 | 2,354,256,829 | 5,750,329,074 | 11,185,188,715 | 5,476,872,137 |
| Net Income | 79,825,675 | 118,460,141 | 119,360,791 | 148,188,701 | 150,406,562 | 293,067,757 | 208,864,316 | 676,997,342 | 2,021,467,667 | 4,735,795,243 | 1,247,679,723 |
| FCF USD | 15,710,647 | 54,999,258 | 73,915,404 | -1,863,269 | -67,685,567 | -37,754,352 | 110,679,818 | 77,769,863 | 634,158,185 | 3,202,681,945 | 378,151,247 |
| OCF USD | 97,829,103 | 132,425,299 | 151,837,500 | 129,401,335 | 146,969,323 | 208,307,316 | 272,680,549 | 468,206,484 | 1,681,947,606 | 4,132,592,572 | 1,537,822,926 |
Financial Health - DEBT
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.79 | 0.07 | 0.10 | 0.03 | 0.02 | 0.02 | 0.10 |
| D/E | 0.08 | 0.05 | 0.00 | 0.00 | 0.25 | 0.02 | 0.01 | 0.03 | 0.06 | 0.02 | 0.02 |
| CA/CL | 2.05 | 2.97 | 1.93 | 1.55 | 1.33 | 2.53 | 1.80 | 2.39 | 1.96 | 3.49 | 3.86 |
| TA/TL | 2.70 | 3.58 | 2.91 | 2.94 | 2.19 | 4.08 | 3.71 | 3.79 | 2.84 | 4.43 | 5.55 |
| Total Debt | 30,235,188 | 31,000,000 | 120,559 | 0 | 218,346,085 | 21,000,000 | 21,000,000 | 77,655,783 | 287,064,545 | 277,855,695 | 208,858,712 |
Management Performance
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 16.19% | 15.22% | 12.40% | 10.95% | 12.71% | 19.84% | 12.66% | 25.12% | 34.42% | 37.84% | 9.49% |
| ROE | 20.89% | 20.41% | 17.30% | 16.67% | 17.12% | 21.71% | 13.40% | 26.51% | 45.26% | 38.37% | 9.82% |
| ROA | 0.00% | 14.71% | 10.84% | 10.19% | 9.08% | 16.14% | 9.71% | 19.46% | 29.51% | 29.97% | 7.94% |
| NM % | 16.00% | 19.87% | 17.53% | 17.56% | 15.84% | 29.82% | 17.64% | 28.76% | 35.15% | 42.34% | 22.78% |
| FCF / R% | 0.00% | 9.22% | 10.86% | -0.22% | -7.13% | -3.84% | 9.35% | 3.30% | 11.03% | 28.63% | 6.90% |
| FCF / NI% | 19.68% | 46.43% | 61.93% | -1.26% | -45.02% | -12.89% | 52.63% | 11.41% | 30.50% | 65.85% | 30.31% |
| Operating Margin (OM) | 0.00 | 0.55 | 0.21 | 0.29 | 0.37 | 0.62 | 0.68 | 0.61 | 0.55 | 0.66 | 1.38 |
Per Share
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.08 | 0.12 | 0.12 | 0.14 | 0.15 | 0.27 | 0.17 | 0.55 | 1.64 | 3.79 | 0.99 |
| SPS | 0.51 | 0.58 | 0.66 | 0.82 | 0.93 | 0.92 | 0.96 | 1.91 | 4.67 | 8.96 | 4.35 |
| OCPS | 0.10 | 0.13 | 0.15 | 0.13 | 0.14 | 0.20 | 0.22 | 0.38 | 1.36 | 3.31 | 1.22 |
| FCPS | 0.02 | 0.05 | 0.07 | 0.00 | -0.07 | -0.04 | 0.09 | 0.06 | 0.51 | 2.57 | 0.30 |
| BVPS | 0.39 | 0.57 | 0.70 | 0.93 | 0.88 | 1.28 | 1.28 | 2.09 | 3.70 | 10.06 | 10.22 |
Per Share - CAGR
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.08 | 0.12 | 0.12 | 0.14 | 0.15 | 0.27 | 0.17 | 0.55 | 1.64 | 3.79 | 0.99 |
| CAGR-SPS | 0.51 | 0.58 | 0.66 | 0.82 | 0.93 | 0.92 | 0.96 | 1.91 | 4.67 | 8.96 | 4.35 |
| CAGR-OCPS | 0.10 | 0.13 | 0.15 | 0.13 | 0.14 | 0.20 | 0.22 | 0.38 | 1.36 | 3.31 | 1.22 |
| CAGR-FCPS | 0.02 | 0.05 | 0.07 | 0.00 | -0.07 | -0.04 | 0.09 | 0.06 | 0.51 | 2.57 | 0.30 |
| CAGR-BVPS | 0.39 | 0.57 | 0.70 | 0.93 | 0.88 | 1.28 | 1.28 | 2.09 | 3.70 | 10.06 | 10.22 |